Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Brazier

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
Health and Quality of Life Outcomes|November 28, 2015
Comparing the measurement equivalence of EQ-5D-5L across different modes of administrationBrendan Mulhern, Hannah O'Gorman, Neil Rotherham, et al.
Social Science & Medicine (1982)|May 3, 2011
Understanding the effect of disease adaptation information on general population values for hypothetical health statesHelen McTaggart-Cowan, Aki Tsuchiya, Alicia O'Cathain, et al.
Pharmacoeconomics|February 27, 2018
3L, 5L, What the L? A NICE ConundrumNancy Devlin, John Brazier, A Simon Pickard, et al.
Pharmacoeconomics|May 11, 2018
Correction to: 3L, 5L, What the L? A NICE ConundrumNancy Devlin, John Brazier, A Simon Pickard, et al.
Health and Quality of Life Outcomes|January 16, 2014
Quality of life impact of mental health conditions in England: results from the adult psychiatric morbidity surveysJennifer Roberts, Pamela Lenton, Anju D Keetharuth, et al.
Pharmacoeconomics|October 21, 2017
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness ModelsJohn Brazier, Roberta Ara, Donna Rowen, et al.
Pharmacoeconomics|October 21, 2017
The Role of Condition-Specific Preference-Based Measures in Health Technology AssessmentDonna Rowen, John Brazier, Roberta Ara, et al.
Health and Quality of Life Outcomes|December 21, 2018
A review of quality of life themes in Duchenne muscular dystrophy for patients and carersLesley Uttley, Jill Carlton, Helen Buckley Woods, et al.
Medical Care|March 30, 2020
Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With DurationBrendan J Mulhern, Nick Bansback, Richard Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 3, 2008
Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese PopulationCindy L K Lam, John Brazier, Sarah M McGhee
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Health and Quality of Life Outcomes|November 28, 2015
Comparing the measurement equivalence of EQ-5D-5L across different modes of administrationBrendan Mulhern, Hannah O'Gorman, Neil Rotherham, et al.
Social Science & Medicine (1982)|May 3, 2011
Understanding the effect of disease adaptation information on general population values for hypothetical health statesHelen McTaggart-Cowan, Aki Tsuchiya, Alicia O'Cathain, et al.
Pharmacoeconomics|February 27, 2018
3L, 5L, What the L? A NICE ConundrumNancy Devlin, John Brazier, A Simon Pickard, et al.
Pharmacoeconomics|May 11, 2018
Correction to: 3L, 5L, What the L? A NICE ConundrumNancy Devlin, John Brazier, A Simon Pickard, et al.
Health and Quality of Life Outcomes|January 16, 2014
Quality of life impact of mental health conditions in England: results from the adult psychiatric morbidity surveysJennifer Roberts, Pamela Lenton, Anju D Keetharuth, et al.
Pharmacoeconomics|October 21, 2017
A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness ModelsJohn Brazier, Roberta Ara, Donna Rowen, et al.
Pharmacoeconomics|October 21, 2017
The Role of Condition-Specific Preference-Based Measures in Health Technology AssessmentDonna Rowen, John Brazier, Roberta Ara, et al.
Health and Quality of Life Outcomes|December 21, 2018
A review of quality of life themes in Duchenne muscular dystrophy for patients and carersLesley Uttley, Jill Carlton, Helen Buckley Woods, et al.
Medical Care|March 30, 2020
Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With DurationBrendan J Mulhern, Nick Bansback, Richard Norman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 3, 2008
Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese PopulationCindy L K Lam, John Brazier, Sarah M McGhee
Pageof 20